黏蛋白1C亚基对食管癌细胞生物学行为的影响

doi:10.6040/j.issn.1671-7554.0.2017.925

摘要/Abstract

摘要： 目的探讨黏蛋白1 C亚基(MUC1-C)在食管鳞癌中的表达定位及在肿瘤细胞恶性生物学行为中的作用。方法 Western blotting检测MUC1-C在食管鳞癌组织及正常组织细胞核内的表达;运用穿膜肽Go-201抑制MUC1-C入核后,集落实验及CCK-8实验检测食管鳞癌细胞的活性、生长和增殖能力;划痕实验及Transwell小室实验检测食管鳞癌细胞迁移及侵袭能力;流式细胞术检测食管鳞癌细胞凋亡率。结果 MUC1-C在食管鳞癌组织细胞核内的表达高于正常组织,抑制MUC1-C入核后食管鳞癌细胞活性、生长、增殖、迁移、侵袭能力均降低,凋亡率增高。结论 MUC1-C通过入核发挥作用,能诱导和促进食管鳞癌细胞的恶性生长、增殖、迁移、侵袭,抑制肿瘤细胞的凋亡。

关键词: 食管鳞癌, 黏蛋白1C亚基, 转移, 凋亡

Abstract: Objective To explore the expression of mucin1-C(MUC1-C)in esophageal squamous cell carcinoma(ESCC)and its role in the malignant biological behaviors of ESCC cells. Methods The expressions of MUC1-C in the ESCC tissues and normal tissues were detected with Western blotting. After MUC1-C entrance into the nucleus was inhibited with Go-201, the activity, growth and proliferation of ESCC cells were assessed with colony-forming assay and CCK-8 test; the cell migration and invasion abilities were measured with wound healing and Transwell assay, respectively; the apoptosis rate was determined with flow cytometry. Results The expression of MUC1-C in ESCC tissues was higher than that in normal tissues. The activity, growth, proliferation, migration and invasion of ESCC cells decreased while the apoptosis rate increased after MUC1-C entrance into the nucleus was inhibited with Go-201. Conclusion MUC1-C can promote the growth, proliferation, migration and invasion while inhibit the apoptosis of ESCC cells.

Key words: Esophageal squamous cell carcinoma, Mucin1-c, Migration, Apoptosis

中图分类号:

R574

公孙鑫,辛钟伟,史墨,秦启明,姜斌,宋学敏,刘相燕. 黏蛋白1C亚基对食管癌细胞生物学行为的影响[J]. 山东大学学报 (医学版), 2018, 56(10): 86-92.

GONGSUN Xin, XIN Zhongwei, SHI Mo, QIN Qiming, JIANG Bin, SONG Xuemin, LIU Xiangyan. Effects of mucin1-C on the biological behaviors of esophageal squamous cell carcinoma cells[J]. Journal of Shandong University (Health Sciences), 2018, 56(10): 86-92.

参考文献

[1] Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12):2893-2917.
[2] Kufe DW. Mucins in cancer: function, prognosis and therapy[J]. Nat Rev Cancer, 2009, 9(12):874-885.
[3] Alam M, Ahmad R, Rajabi H, et al. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells[J]. J Biol Chem, 2013, 288(43):30892-30903.
[4] Martin JC, Herbert BS, Hocevar BA. Disabled-2 downregulation promotes epithelial-to-mesenchymal transition[J]. Bit J Cancer, 2010, 103(11):1716-1723.
[5] Leng Y, Cao C, Ren J, et al. Nuclear import of the MUC1-C oncoprotein is mediated by nucleoporin Nup62[J]. J Biol Chem, 2007, 282(27):19321-19330.
[6] Takahashi H, Jin C, Rajabi H, et al. MUC1-C activates the TAK1 inflammatory pathway in colon cancer[J]. Oncogene, 2015, 34(40):5187-5197.
[7] Huang HL, Wu HY, Chu PC, et al. Role of integrin-linked kinase in regulating the protein stability of the MUC1-C oncoprotein in pancreatic cancer cells[J]. Oncogenesis, 2017, 6(7):e359. doi:10.1038/oncsis.2017.61.
[8] Bouillez A, Rajabi H, Pitroda S, et al. Inhibition of MUC1-C suppresses MYC expression and attenuates malignant growth in KRAS mutant lung adenocarcinomas[J]. Cancer Res, 2016, 76(6):1538-1548.
[9] Tagde A, Rajabi H, Bouillez A, et al. MUC1-C drives MYC in multiple myeloma[J]. Blood, 2016, 127(21):2587-2597.
[10] Kharbanda A, Rajabi H, Jin C, et al. MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells[J]. Oncotarget, 2014, 5(19):8893-8905.
[11] Rajabi H, Tagde A, Alam M, et al. DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells[J]. Oncogene, 2016, 35(50):6439-6445.
[12] Siddique HR, Saleem M. Role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences[J]. Stem Cells, 2012, 30(3):372-378.
[13] Hiraki M, Maeda T, Bouillez A, et al. MUC1-C activates BMI1 in human cancer cells[J]. Oncogene, 2017, 36(20):2791-2801.
[14] David JM, Hamilton DH, Claudia P. MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition[J]. Oncoimmunology, 2016, 5(4):e1117738. doi:10.1080/2162402X.2015.1117738.
[15] Bouillez A, Rajabi H, Jin C, et al. MUC1-C integrates PD-L1 induction with repression of immune effectors in non-small-cell lung cancer[J]. Oncogene, 2017, 36(28):4037-4046.
[16] Raina D, Agarwal P, Lee J, et al. Characterization of the MUC1-C cytoplasmic domain as a cancertarget[J]. PLoS One, 2015, 10(8):e0135156. doi:10.1371/journal.pone.0135156.eCollection 2015.
[17] Sun ZG, Wang Z, Liu XY. Mucin 1 and vascular endothelial growth factor C expression correlates with lymph node metastatic recurrence in patients with N0 esophageal cancer after Ivor-Lewis esophagectomy[J]. World J Surg, 2011, 35(1):70-77.
[18] Li SH, Wang Z, Liu XY, et al. Lymph node micrometastasis: a predictor of early tumor relapse after complete resection of histologically node-negative esophageal cancer[J]. Surg Today, 2007, 37(12):1047-1052.
[19] 王衍泽, 管向臣, 史墨, 等. RNA干扰沉默黏蛋白1基因表达对食管癌细胞株Eca109顺铂耐药性的影响[J]. 中华实验外科杂志, 2017, 34(9):1476-1478. WANG Yanze, GUANXiangchen, SHI Mo, et al. Effects of silencing mucin 1 with RNA interference on drug resistance of esophageal squamous cell carcinoma Eca109 to cisplatin[J]. Chin J Exp Surg, 2017, 34(9):1476-1478.

相关文章 15

[1]	张士宝刘庆勇阮喜云陈杰张建军李宗武杨广笑王全颖. NT₄-SAC-HA₂-TAT融合基因表达载体的构建及鉴定[J]. 山东大学学报(医学版), 2209, 47(6): 15-19.
[2]	鹿向东杨伟徐广明曲元明. 脑膜瘤中PPAR-γ的表达及曲格列酮对脑膜瘤培养细胞生长的影响[J]. 山东大学学报(医学版), 2209, 47(6): 65-.
[3]	陈杨,冯莹,卢晓,郑蓉. 半乳糖凝集素-3通过PI3K/Akt/mTOR通路促进巨噬细胞自噬分化[J]. 山东大学学报 (医学版), 2026, 64(4): 14-22.
[4]	殷悦,莫振飞,吴培昕,刘金霞,魏元辉,任佳博,李春笋. GPX1基因在肺癌中的表达特征及其对肺腺癌细胞增殖、迁移、侵袭、凋亡的影响[J]. 山东大学学报 (医学版), 2026, 64(1): 65-73.
[5]	韩觉明,王晖,吴倩,郑慧玲,朱琳. B4GALNT4促进肺腺癌细胞增殖、迁移和侵袭能力[J]. 山东大学学报 (医学版), 2025, 63(7): 23-31.
[6]	张洁,赵颖慧,董雅琪,李娟,李培龙,杜鲁涛. GPR133基因甲基化在早期胃癌淋巴结转移预测中的作用[J]. 山东大学学报 (医学版), 2025, 63(3): 76-84.
[7]	李响,张艺,王雪纯,徐梦超,王月兰. 氧化应激在创伤性脑损伤诱发急性肺损伤中的研究进展[J]. 山东大学学报 (医学版), 2025, 63(2): 118-124.
[8]	张洁,张芳芳,王靖楠,李泽宇,宋颖,李娜. circ_0000144在乳腺癌中的表达及其对乳腺癌细胞增殖、迁移和侵袭能力的影响[J]. 山东大学学报 (医学版), 2025, 63(1): 35-42.
[9]	孙婧,杨瑞敏,王聪,张月,罗兵. 基于术前超声、炎症指标及超声影像组学联合模型预测乳腺癌腋窝淋巴结转移[J]. 山东大学学报 (医学版), 2025, 63(1): 73-80.
[10]	杜学识,倪向敏,梁馨予,白倩,朱文艺,王建. 雌马酚对DN的保护作用及潜在靶点[J]. 山东大学学报 (医学版), 2024, 62(8): 49-58.
[11]	王静,刘晓菲,曾荣,许长娟,张锦涛,董亮. 基于机器学习算法鉴定哮喘的坏死性凋亡相关生物标志物[J]. 山东大学学报 (医学版), 2024, 62(7): 21-32.
[12]	宋艳艳,左淑英. 透明细胞肾细胞癌颌下腺转移1例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(7): 120-124.
[13]	林雨洋,王蓓,李菲. 大于10 mm甲状腺乳头状癌侧颈区淋巴结转移预测[J]. 山东大学学报 (医学版), 2024, 62(6): 54-64.
[14]	冯绪梅,宋相庆,季冠虹,赵小刚,肖兆华. 血浆外泌体miR-548k在食管鳞癌中的表达及诊断价值[J]. 山东大学学报 (医学版), 2024, 62(5): 79-88.
[15]	吴霖,石晨曦,童星. 肺良性转移性平滑肌瘤病7例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(4): 78-84.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed